Pages that link to "Q61053086"

The following pages link to Neuroprotective and Intraocular Pressure-Lowering Effects of (–)Δ 9 -Tetrahydrocannabinol in a Rat Model of Glaucoma (Q61053086):

Displaying 20 items.

• Endocannabinoids in the retina: from marijuana to neuroprotection (Q24656049) (← links)
• The Endocannabinoid System as a Therapeutic Target in Glaucoma (Q26765508) (← links)
• The Endocannabinoid System in the Retina: From Physiology to Practical and Therapeutic Applications (Q26765747) (← links)
• Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability. (Q33558455) (← links)
• Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy (Q34325015) (← links)
• A GPR18-based signalling system regulates IOP in murine eye. (Q34331021) (← links)
• Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins (Q35100405) (← links)
• Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection (Q37301639) (← links)
• Ocular disposition of the hemiglutarate ester prodrug of ∆⁹-Tetrahydrocannabinol from various ophthalmic formulations (Q37364200) (← links)
• Role of adenosine in diabetic retinopathy. (Q38073250) (← links)
• Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation (Q38087533) (← links)
• Neuroprotection by (endo)cannabinoids in glaucoma and retinal neurodegenerative diseases. (Q38664371) (← links)
• Intraocular pressure-lowering effect of oral paracetamol and its in vitro corneal penetration properties (Q41833978) (← links)
• Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides (Q42943389) (← links)
• The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice. (Q48190647) (← links)
• Novel therapeutics in glaucoma management (Q50023818) (← links)
• Ocular Disposition of ∆8-Tetrahydrocannabinol from Various Topical Ophthalmic Formulations. (Q53130043) (← links)
• Medical Use of Cannabinoids (Q58102489) (← links)
• Δ9-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits (Q90537165) (← links)
• Wikidata:WikiProject Chronic Pain/Tetrahydrocannabinol (← links | edit)